Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

Tuesday, March 25, 2025 at 8:30 a.m. ET President and Chief Executive Officer — Paul Sternlieb Organic Sales Growth -- 5% ...